The Pharma Letter23h
Lilly drops on disappointing guidance
Eli Lilly saw its shares close down 6.6% at $744.91 yesterday, after it revealed forecast for sales at the JP Morgan ...
Le Lézard13h
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
InnovationRx: A Flurry Of Deals And A Lot Of Uncertainty At The J.P. Morgan Healthcare Conference
Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...
US FDA approves expanded use of Lilly's bowel disease drug
Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
News Medical on MSN6h
Targeting tertiary lymphoid structures for cancer treatment
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell clusters called tertiary lymphoid structures (TLSs) in response to foreign ...
Biden administration moves to limit nicotine in cigarettes and certain other tobacco products
The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of ...